skip to main content

Pharmaceutical Company Threatens Blogger

Boiron pharmaceutical company threatens legal action against a blogger criticizing homeopathy and its flu remedy, Oscillococcinum.

Written byNeuroskeptic
| 1 min read
Follow on GoogleGoogle News Preferred Source
Placeholder image

Newsletter

Sign up for our email newsletter for the latest science news

Sign Up

Boiron, a multinational pharmaceutical company, have threatened an Italian blogger with legal action, the BMJ reports.

Placeholder image showing Earth from space with an alert icon and the message ‘This image is no longer available.’

Many people are concerned when big pharmaceutical companies do this kind of thing. So I don't think we should make any exception merely because Boiron's pharmaceuticals happen to be homeopathic ones.

Samuel Riva, who blogs (in Italian) at blogzero.it, put up some articles critical of homeopathy

which included pictures of Boiron’s blockbuster homoeopathic product Oscillococcinum, marketed as a remedy against flu symptoms. The pictures were accompanied by captions, which joked about the total absence of any active molecules in homoeopathic preparations

Boiron wrote to Riva's internet provider threatening legal action, if the offending references to Boiron weren't taken down. They also wanted them to lock Riva out of his blog, the BMJ says. In response Riva removed the references to Boiron, including the pictures and captions, but kept the posts on homeopathy in general.

Hmmm.

Above you can see a new picture I made of a Boiron product, with some captions you may find interesting. I've made sure to limit these to quotes from Wikipedia, and from Boiron USA's own website, and some simple mathematical calculations.

Beyond that, I make no comment whatsoever.

Placeholder image showing Earth from space with an alert icon and the message ‘This image is no longer available.’

Turone F (2011). Homoeopathy multinational Boiron threatens amateur Italian blogger. BMJ (Clinical research ed.), 343 PMID: 21840920

Meet the Author

Stay Curious

JoinOur List

Sign up for our weekly science updates

View our Privacy Policy

SubscribeTo The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Subscribe